Introduction (a) Obsessive-compulsive disorder is a severe and chronic disorder with limited pharmacologic treatment options
Obsessive compulsive disorder (OCD) is a severe mental illness characterized by intrusive thoughts (obsessions) and repetitive acts (compulsions) [1, 2] . These symptoms can be highly disruptive, leading to a significant impact on quality of life. In addition, the annual financial cost associated with OCD in the USA is estimated at $10 billion [3] . Accordingly, the World Health Organization has identified OCD as a major cause of illness-related disability, underscoring both the heavy burden this disorder places on patients and the steep cost to society at large [1, 2, 4] . Globally, OCD has a lifetime prevalence of 2-3% (i.e. two to three times more common than schizophrenia) [5, 6] . Since illness onset often occurs during childhood or adolescence, and symptoms continue throughout life, this chronic disorder leads to significant morbidity [3] . OCD is therefore not only a devastating psychiatric illness, it is also extremely widespread.
Despite the high prevalence and severity of OCD, the underlying pathophysiologic mechanisms are still unclear. This lack of understanding of the neural basis of pathology limits the development of effective treatments. Current estimates indicate that approximately half of all patients have only partial responses to available pharmacologic treatments, and up to 10% are treatment resistant, meaning even our best treatments leave many patients without relief. Thus, in order to improve treatment of OCD, we need further research to identify the neural substrates of obsessions and compulsions.
In this manuscript, we use original research to highlight basic monoaminergic disruptions in a genetic knockout (KO) mouse model relevant to OCD. We then expand on how nuanced techniques for controlling and monitoring cellular activity could further elucidate the role of these monoaminergic abnormalities in future experiments. Thus, we provide a traditional, static view of dysregulation in the context of an OCD-related model, followed by a look towards cutting-edge approaches that will need to be implemented to expand our knowledge of neuronal circuit abnormalities relevant to OCD-related symptoms.
(b) Evidence from clinical obsessive-compulsive disorder studies suggests dysfunction in monoaminergic systems
While substantial research has focused on the role of corticostriatal-thalamo-cortical circuits in OCD [1, 2, 7, 8] , particularly emphasizing the orbitofrontal cortex (OFC) and striatum, monoamine dysfunction served as a major focus of early human studies of OCD pathophysiology [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . For over 30 years, it has been hypothesized that serotonergic dysfunction is central to OCD pathophysiology [18] . This hypothesis was initially grounded in the finding that serotonin reuptake inhibitors (SRIs), including both clomipramine and selective SRIs, were efficacious in treating a subset of OCD patients [17] [18] [19] . Furthermore, symptom exacerbation generally occurs when targeting receptors that negatively regulate presynaptic serotonin release [20, 21] , suggesting that deficient serotonin signalling contributes to OCD. In addition, associations of serotonin transporter gene polymorphisms with OCD [22] [23] [24] [25] [26] [27] [28] have led to speculation that OCD is associated with a hyposerotonergic state. However, many inconsistencies have made it difficult to isolate specific abnormalities within the serotonergic system. For example, OCD patients and healthy controls show similar levels of plasma serotonin and cerebrospinal serotonin and metabolites [29] [30] [31] , but recent work indicates that plasma serotonin concentration is positively correlated with OCD symptom reduction [30] . In addition, agonists can reduce or exacerbate OCD symptoms depending on the drug's receptor subtype affinity [28, 31] . Because these approaches are unable to detect localized serotonergic disruptions in specific brain regions, they are unable to detect selective dysregulation of specific cortical and striatal serotonin inputs.
Similar challenges have been encountered during attempts to identify OCD-related pathologic changes in the dopaminergic system. Dopaminergic receptor antagonist augmentation of SRIs is efficacious in a subset of subjects with OCD [10, 13, [32] [33] [34] . Coupled with findings of reduced dopamine D1 and D2 receptor binding in the striatum [12, 13, 35, 36] and exacerbation of OCD symptoms by indirect dopamine receptor agonists (cocaine, amphetamine, methylphenidate) [10] , these clinical data would be consistent with a potential hyperdopaminergic state in people with OCD. However, these findings have not been consistently replicated [2, 10] , making the role of dopamine signalling in OCD unclear.
(c) Animal models are a powerful tool for investigating obsessive-compulsive disorder pathophysiology
The need for an improved understanding of the role of monoamines in the development, expression and treatment of OCD symptoms is clear. Although human studies are crucial for these efforts, they have inherent limitations due to their noninvasive nature. Animal studies of monoaminergic signalling are therefore essential to complement the human OCD literature by directly addressing questions of mechanism. One of the best currently available OCD-relevant genetic animal models is the SAPAP-3 KO mouse. SAPAP-3 is a post-synaptic density protein found at excitatory synapses, and is highly enriched in striatum relative to other SAPAP gene family members [37] [38] [39] [40] . SAPAP-3 has been linked to OCD and related disorders including trichotillomania and skin picking via genetic studies in humans [41, 42] , strengthening its translational relevance. In addition to face validity (compulsive-like grooming behaviour accompanied by anxiety), SAPAP3-KOs have predictive validity, since chronic fluoxetine treatment ameliorates these behaviours [43] . Furthermore, SAPAP-3 KOs also show increased in vivo baseline striatal activity [44] and decreased fEPSPs in dorsolateral striatum slices [43] , providing a potential link to human OCD functional imaging studies. This well-validated OCD-relevant animal model is now being used by numerous groups to investigate the neural mechanisms underlying compulsive-like behaviours [43] [44] [45] . Despite the growing use of SAPAP-3 KOs for translational OCD research, monoamine levels and turnover have not yet been examined in this model. To determine whether SAPAP3-KOs have monoaminergic abnormalities in prefrontal cortical and striatal subregions that have been consistently linked to OCD symptoms [1, 8] and OCD-related phenotypes in animal models [2, [43] [44] [45] [46] [47] , we used HPLC to characterize dopamine, serotonin and their metabolites in post-mortem OFC (medial and lateral), mPFC, dorsal striatum (DS) and ventral striatum (VS) of SAPAP-3 KO mice and wild-type (WT) controls. This strategy allowed us to determine if global abnormalities in monoamine function are present in SAPAP-3 KOs, an important first step in investigating cortical and striatal neurochemical abnormalities in this OCD model. Video data were analysed offline by a pair of highly trained raters blinded to experimental conditions. Thirty minute videos were scored in 5 min bins for time spent grooming (defined as clearly visible cleaning or smoothing of the skin and fur with the mouth, front paws or hind paws). Each rater scored videos independently and without knowledge of the other rater's scores to ensure behavioural assessment was robust to errors in subjective ratings. Reported data are averaged between assessments and raters, except where otherwise noted.
Methods

(i) Tissue acquisition
Animals were sacrificed 3 days after grooming assessments during the light cycle using cervical dislocation, and brains were rapidly removed for slicing in ice-cold phosphate buffered saline. 0.7 mm thick coronal sections were cut at þ2.77 mm, þ1.97 mm and þ1.21 mm anterior to Bregma [48] . Each section was then rapidly frozen on dry ice. 1.0 mm diameter tissue punches were then obtained from both hemispheres of lateral orbitofrontal cortex (lOFC) and medial orbitofrontal cortex (mOFC) (figure 1). A 1.75 mm diameter punch was taken from the midline of a medial prefrontal cortex (mPFC) section containing the prelimbic and infralimbic mPFC (figure 1). 1.0 mm diameter punches were obtained from both hemispheres of VS and DS. The DS section contained both dorsolateral and dorsomedial striatal subregions (figure 1). For a single subject, sections from both hemispheres were pooled together in a tube, and stored at 2808C prior to HPLC analysis.
(ii) Neurochemical detection via HPLC All neurochemical assays were conducted at the University of Vanderbilt Neurochemistry Core (Biogenic Amines Assay); samples were shipped on dry ice. Brain sections were homogenized using a tissue dismembrator in 100 -750 ml 0.1 M TCA (10-2 M sodium acetate, 10 -4 M EDTA, 5 ng ml 21 isoproterenol (as internal standard); 10.5% methanol ( pH 3.8)). Ten microlitres of homogenate were used for each protein assay. Samples were spun in a microcentrifuge at 10 000 g for 20 min and supernatant was removed for biogenic monoamine analysis with HPLC. Remaining samples were stored at -808C for future use.
Biogenic amines were determined by a specific HPLC assay using an Antec Decade II (oxidation: 0.65) electrochemical detector operated at 338C. 20 ml samples of the supernatant were injected using a Water 2707 autosampler onto a Phenomenex Kintex (2.6u, 100A) C18 HPLC column (100 Â 4.60 mm). Biogenic amines were eluted with a mobile phase consisting of 89.5% 0.1 M TCA, 10-2 M sodium acetate, 10-4 M EDTA and 10.5% methanol ( pH 3.8). Solvent was delivered at 0.6 ml min 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), serotonin 5-HT and 3-methoxytyramine (3-MT). HPLC control and data acquisition were managed by Empower software.
Protein concentration was determined by BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA). 10 ml of tissue homogenate from each sample was placed into a 96-well plate; 200 ml of mixed BCA reagent (25 ml of Protein Reagent A mixed with 500 ml of Protein Reagent B) was then added. The plate was incubated at room temperature for 2 h for colour development while a BSA standard curve was run. Absorbance was measured on a plate reader (POLARstar Omega; BMG LABTECH, Ortenberg, Germany).
(iii) Data analysis
All data analysis was conducted with custom Matlab scripts (ver. 2016a, MathWorks, Natick, MA) and SPSS statistical analysis software (IBM, Armonk, NY). Each animal's grooming data were averaged across both raters' assessments of both test sessions. Thus, each animal's grooming was an average of four ratings to minimize bias between raters and variability between test sessions. Time spent grooming was not normally distributed and non-parametric statistics were used as appropriate. Effects of sex and genotype on total grooming were assessed via a pair of Mann -Whitney tests with Bonferroni corrections for multiple comparisons. Data are reported as corrected p-values. Genotype effects on time spent grooming were also analysed for males and females separately using a Mann -Whitney procedure. Inter-rater reliability was calculated via the intraclass correlation (single measures; absolute agreement, one-way random raters model), and differences between rater's scores were assessed via Wilcox signed-rank test. Consistency across days within a rater was assessed with Spearman's correlation of each animal's total time grooming in assessment 1 and 2.
Differences in neurochemical content were assessed via analysis of variance (ANOVA) with sex, genotype and brain region as fixed factors (2 Â 2 Â 5 ANOVA). Main effects of brain region are not of central interest, as effects related to genotype were the main focus of the current study. For a given neurochemical, significant interactions between region and genotype were analysed with Bonferroni corrected post hoc independent samples t-tests on each region's data from SAPAP-3 KO and WT mice. All reported post hoc p-values were Bonferroni corrected.
We calculated the Spearman's rank correlation between neurochemical levels and grooming for samples that were significantly different according to genotype, pooling WT and SAPAP3 2/2 animals. All resulting p-values for this exploratory analysis are reported prior to Bonferroni correction.
Results (a) SAPAP-3 knockouts demonstrate excessive grooming
Consistent with previous reports [43, 44] , time spent grooming was increased in SAPAP-3 KOs relative to WT controls (figure 2; U ¼ 56, Z ¼ 23.596, p , 0.001). These effects were similar when male (U ¼ 2, Z ¼ 23.151, p ¼ 0.004) and female (U ¼ 28, Z ¼ 22.037, p ¼ 0.042) animals were considered separately, and there was no effect of sex on time spent grooming (U ¼ 130, Z ¼ 21.360, p ¼ 0.348). Total time grooming was highly correlated between both raters (intraclass correlation ICC 37,38 ¼ 0.994, p , 0.001), and grooming values did not significantly differ between them (Wilcox signed-rank test, Z 1 ¼ 1.617, signed rank ¼ 482, p ¼ 0.106, median rater 1: 300.40, median rater 2 ¼ 284.43). For both raters, each animal's total time grooming was highly correlated across days (rater 1, r ¼ 0.784, p , 0.001; rater 2, r ¼ 0.823, p , 0.001).
(b) Tissue samples
In order to assess post-mortem differences in monoamine neurochemistry between SAPAP-3 KO and WT mice, we collected bilateral lOFC, mOFC, mPFC, DS and VS from males and females of both genotypes. (e) Relationship between grooming levels and monoaminergic abnormalities in SAPAP3-knockouts
As a first attempt to elucidate the relationship between neurochemical alterations and behavioural abnormalities in SAPAP3-KOs, we performed an exploratory analysis to correlate grooming with each HPLC sample that differed 
Discussion
As expected based on previous studies, SAPAP-3 KO mice displayed excessive grooming [43] . In the same animals, we found evidence of serotonergic dysregulation (5HIAA and 5HIAA/ serotonin ratio) in mOFC, lOFC, mPFC and dorsal and VS. We also observed evidence of dopamine abnormalities in OFC. Specifically, the ratio of HVA/dopamine was increased in lateral and medial OFC, and the ratio of DOPAC/dopamine was increased in lateral OFC. These findings are suggestive of increased cortical and striatal monoamine release in SAPAP-3 KO mice. They also align with a larger literature associating OCD with aberrant monoamine signalling [2, 10, 15, 16, 18] and documenting dysregulated neural activity in frontal cortex and striatum of both OCD patients and several animal models relevant to OCD [19, [52] [53] [54] .
(a) Serotonergic disruptions in SAPAP-3 knockout mice
These data are the first evidence of serotonergic abnormalities in SAPAP-3 KO mice, a validated animal model of compulsive-like behaviours [43, 47, 55] . To date most studies using SAPAP-3 KOs have focused on cortical and striatal systems [43 -45,56] ; our results therefore set the stage for more expansive investigation of the monoaminergic mechanisms underlying compulsive-like behaviours. Though SAPAP-3 is enriched in striatal regions relative to other SAPAP gene family members, it is also present in other brain regions [43, 57] . Constitutive knock out of SAPAP-3 could therefore potentially impact monoaminergic signalling via multisynaptic circuits either including or bypassing the striatum. For example, although this hypothesis has not yet been tested, SAPAP-3 deletion could generate dysregulated activity throughout cortico-striatal-thalamo-cortical circuits [58] [59] [60] [61] , leading to hyperactivity in descending projections from cortex to serotonin neurons in the raphe [62, 63] . In turn, this could ultimately cause increased serotonin release in cortical and striatal regions. Further work is needed to directly elucidate how SAPAP-3 genetic deletion affects monoaminergic neural activity. Our data suggest that serotonin release and metabolism are increased in cortex and striatum of SAPAP-3 KO mice. These preclinical data may seem somewhat at odds with some clinical data. For instance, the utility of SRIs in treating OCD symptoms [19, 64] , decreased serotonin transporter availability [28, 31, [65] [66] [67] [68] [69] , and associations of polymorphisms of the genes encoding serotonin transporter [22] [23] [24] [25] [26] [27] [28] and serotonin 2A receptor [23] proteins with OCD have led to speculation that OCD is associated with a hypo-serotonergic state. However, it is important to note that the serotonin hypothesis has mixed support [1] . For instance, though the majority of the available clinical data suggest that OCD is associated with hypo-serotonergia, acute doses of metachlorophenylpiperazine (a serotonergic agonist) increase symptoms in OCD patients [70] . These data led to speculation that chronic treatment with SRIs induces adaptive hyposerotonergic states [71] . Further supporting the notion that OCD symptoms can be driven by increased serotonin release, SRI administration in OCD patients is correlated with decreased 5HIAA in cerebrospinal fluid [72] and decreased platelet serotonin concentrations [73] .
There are several important considerations for interpreting the current data and comparing them to clinical observations. First, HPLC measurements from post-mortem tissue combine intracellular and extracellular serotonin, leading to challenges in making direct comparisons to human studies monitoring extracellular peripheral levels of neurotransmitter. HPLC also directly measures neurochemical levels, without inferring function through genetic expression or transporter availability. Second, increased serotonin turnover in SAPAP3-KOs could result from increased serotonin metabolism without changes in release. Third, assessment of these neurochemicals is often done in conjunction with a manipulation of neuronal activity (e.g. a drug or stimulation of a neuronal system), and it may therefore be more difficult to interpret the basal neurochemical levels obtained in our study. Fourth, it is unclear if these neurochemical abnormalities disrupt brain or behaviour function, and they could instead represent a compensatory process. This could be consistent with the absence of correlations between post-mortem monoamine content and the observed grooming phenotype that survived multiple comparisons. Finally, because mice cannot model all aspects of a human psychiatric disorder, it is possible that the SAPAP3-KO model does not accurately reflect serotonergic pathology in OCD patients.
In vivo studies in SAPAP3-KOs examining the relationship between monoaminergic signalling and behaviour will yield more insight into these possibilities.
(b) Evidence of dopaminergic abnormalities in SAPAP-3 knockout orbitofrontal cortex
Our data are consistent with dysregulation of dopamine specifically in OFC of SAPAP3-KO mice, lending further support to an extensive literature associating abnormal dopamine transmission with dysregulated behavioural organization. For example, systemic administration of D1-receptor agonists or constitutive knockdown of the dopamine transporter can lead to compulsive-like grooming behaviour [74] [75] [76] [77] .
In addition, compulsive-like checking behaviours can be induced by D2-receptor agonists [78, 79] . Our observation of increased dopamine turnover in OFC could contribute to compulsive-like behaviours in several ways. For example, OFC is essential for performing reward value comparisons and stimulus-outcome associations [80] [81] [82] [83] [84] [85] . Dysregulated dopamine signalling in OFC could therefore lead to deficits in comparison of actual and expected rewards [86, 87] , ultimately leading to repeated perseverative performance of an action. In addition, OFC is strongly associated with behavioural flexibility in the context of reversal learning, and OCD patients have consistently demonstrated abnormal performance and/or neural activity on this task [52, 88] . Thus, impaired dopamine signalling in OFC could impact the ability to learn new rules, contributing to cognitive inflexibility in OCD.
Although we selectively observed increased dopamine turnover in OFC, aberrant behavioural selection is less commonly associated with dopamine signalling within the OFC, and more commonly associated with striatal and mPFC dopamine signalling [86, [89] [90] [91] [92] . Our data may therefore point to a unique regional mechanism of monoaminergic dysfunction relevant to OCD. Of particular interest in this context is the fact that dopaminergic innervation of OFC is relatively weak compared with striatum and mPFC [93] ; thus, modest abnormalities in OFC dopamine levels could represent a strong functional change in OFC. It will therefore be important to use in vivo approaches to precisely measure or control OFC dopamine signalling and examine the impact on performance of tasks impaired in OCD.
(c) Emerging technologies to further understand monoaminergic dysfunction in obsessive-compulsive disorder
More work is necessary to relate our findings to dynamic interactions between networks and resulting behaviours. For instance, monoaminergic abnormalities were not correlated with the compulsive grooming phenotype after corrections for multiple comparisons. However, this does not rule out a role for these changes in abnormal grooming, since a static and non-time-locked alteration in monoamine levels may not necessarily be directly related to a temporally fluctuating behavioural phenotype like grooming. The use of optogenetics to precisely control dopamine and serotonin signalling is an effective way to solve this problem, and this approach will be essential for elucidating the role of monoaminergic signalling in compulsive-like behaviour. However, it is also critical to develop strategies to optimize use of this technology by determining (1) when to optogenetically modulate these systems in relationship to behaviour, and (2) how to pattern optical stimulation, in order to elucidate the neural mechanisms that give rise to compulsive-like phenotypes. Timing of light delivery: After over a decade of advances, neuroscientists are now poised to refine optogenetics to explore increasingly complex questions regarding the relationship between neural activity and behaviour. Behavioural statedependent optogenetics is a nuanced approach to understanding when to optogenetically target monoaminergic activity relative to naturalistic behaviours. The strength of this This projection system is traditionally linked to movement initiation [60, 95] . A clear prediction is that stimulating direct pathway neurons should therefore initiate and sustain behavioural sequences [96] . Stimulation of the direct pathway sustained ongoing behavioural sequences as predicted. However, stimulation also delayed action initiation when applied prior to sequence execution. The latter finding is contrary to theory and demonstrates that optogenetic effects of stimulation depended on the animal's ongoing behaviour. Simply stimulating without taking behavioural state into account would not have uncovered this important distinction. This demonstrates a more subtle relationship between action execution/ movement and the direct pathway than previously theorized. A similar approach has been used to reveal how the amygdala contributes to an opposing relationship between grooming and attack behaviours [97] . Specifically, optogenetic modulation of medial amygdala glutamatergic and GABAergic neurons during distinct behavioural states revealed that the circuits controlling self-grooming and attack behaviours are mutually antagonistic. These examples highlight the potential utility of state-dependent optogenetics to reveal complex relationships between compulsive-like grooming and monoaminergic activity that would be difficult to disentangle using standard optogenetic approaches.
State-dependent optogenetics can be further enhanced by 'closed-loop' approaches, which automatically detect ongoing neural activity or behaviours of interest to trigger optogenetic modulation [98] [99] [100] [101] [102] [103] [104] [105] . Although this approach was first applied in an in vitro electrophysiological setting [100] , more recent applications have focused on real-time in vivo modulation of seizure activity [98, 101, 102, 105] , memory consolidation [103, 106] and somatosensation [99] . Building on this work, on-line detection of behavioural phenotypes, closedloop optogenetics, and state-dependent modulations of neural activity will be important tools for elucidating the relationship between monoamine signalling and naturalistic compulsive-like phenotypes in SAPAP-3 KO mice.
Characteristics of light stimulation patterns: How optogenetic stimulation is patterned is another crucial parameter for optimization. While non-physiological modulation patterns have led to extremely important advances in neuroscience, it is clear that mimicking naturally occurring patterns of activity and determining how these patterns contribute to complex behaviours is an important next step.
Step-function opsins offer one approach for studying how naturalistic patterns of activity impact behavioural phenotypes. These opsins create a stable step in membrane potential when activated by light, and therefore modulate excitability while preserving local circuit dynamics and the relative weight of excitatory and inhibitory inputs [107] [108] [109] [110] [111] . Thus, step-function opsins make targeted neurons more responsive to excitatory neurotransmitter release without directly causing neural firing. Frame-projected independent-fibre photometry is an alternative approach that allows naturally occurring levels of activity to be imaged and then optogenetically mimicked in the same population of neurons [112] . We propose that the use of these tools to naturalistically modulate the excitability of dopamine and serotonin neurons will be a powerful approach for elucidating the role of monoaminergic neurons in development and expression of compulsive-like phenotypes.
Conclusion
Our findings highlight disruptions in monoamine signalling in the OCD-relevant SAPAP3-KO mouse model, and serve as a starting point for future circuit-based investigation of the role of serotonin and dopamine signalling in compulsive-like behaviours. The current data suggest that dopamine signalling from ventral tegmental area to OFC may be a specific source of pathology in SAPAP-3 KO mice, and that serotonergic signalling may be impacted across cortical and striatal circuits, potentially pointing to global dysregulation in serotonergic tone. This study is therefore an important first step towards targeting distinct cortico-striatal circuits and monoamine systems with advanced optogenetic techniques to facilitate dynamic modulation. With this expanded technological toolbox and sophisticated behavioural paradigms, future studies will implement behaviour state-dependent and naturalistic optogenetic manipulations of dopaminergic and serotonergic neurons to assess how their dysfunction may play a role in compulsive-like behaviours. 
